US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

2.68

+0.11004.28%

Post-market: 2.750.0699+2.61%19:58 EDT

Volume:16.67M

Turnover:43.33M

Market Cap:894.94M

PE:-2.17

High:2.71

Open:2.50

Low:2.45

Close:2.57

Loading ...

Overview Company News Filings

Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025

Iovance Biotherapeutics Shares up 17%

THOMSON REUTERS

Iovance Biotherapeutics Shares up 19.8% Premarket

THOMSON REUTERS

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics appoints Roche as CFO

Goldman Sachs Downgrades Iovance Biotherapeutics to Sell From Buy, Adjusts Price Target to $1 From $8

MT Newswires Live

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Barclays Reaffirms Their Buy Rating on Iovance Biotherapeutics (IOVA)

Iovance Says Amtagvi Shows 49% Response Rate in Real-World Skin Cancer Study

MT Newswires Live

Iovance Biotherapeutics Unveils Corporate Presentation Highlighting Global Leadership and Pipeline in TIL Therapy for Cancer

Iovance Biotherapeutics announces real-world study data on Amtagvi

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Iovance Biotherapeutics Files Initial Ownership Statement for Matthew W. Rosinack, SVP Finance

Press Release: Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

Is This Beaten-Down Stock a Millionaire Maker?

Iovance Biotherapeutics Appoints Matthew W. Rosinack as Interim Principal Financial Officer Following Departure of Jean-Marc Bellemin

BRIEF-Iovance Biotherapeutics Says Confirming Resignation Of Chief Financial Officer Jean-Marc Bellemin, Effective July 10, 2025

Gene Therapy Stocks Fall as FDA Pushes Out Another Top Regulator -- Barrons.com

Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart

MT Newswires Live

Iovance Biotherapeutics Inc. Announces CFO Jean-Marc Bellemin's Resignation Effective July 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IOVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IOVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOVA\",,,,,undefined,":{"symbol":"IOVA","market":"US","secType":"STK","nameCN":"Iovance Biotherapeutics, Inc.","latestPrice":2.68,"timestamp":1754078400000,"preClose":2.57,"halted":0,"volume":16672516,"hourTrading":{"tag":"盘后","latestPrice":2.7499,"preClose":2.68,"latestTime":"19:58 EDT","volume":161533,"amount":436726.7503,"timestamp":1754092731214},"delay":0,"floatShares":280260411,"shares":333934387,"eps":-1.234591,"marketStatus":"Market Closed","change":0.11,"latestTime":"08-01 16:00:00 EDT","open":2.5,"high":2.71,"low":2.45,"amount":43333156.2022352,"amplitude":0.101167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.234591,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.57,"preHourTrading":{"tag":"盘前","latestPrice":2.48,"preClose":2.57,"latestTime":"09:28 EDT","volume":286407,"amount":715666.4509401,"timestamp":1754054899889},"postHourTrading":{"tag":"盘后","latestPrice":2.7499,"preClose":2.68,"latestTime":"19:58 EDT","volume":161533,"amount":436726.7503,"timestamp":1754092731214},"volumeRatio":0.8726528774616679,"impliedVol":1.3793,"impliedVolPercentile":0.916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOVA\",,,,,undefined,":{"symbol":"IOVA","floatShares":280260411,"roa":"-27.14%","roe":"-51.85%","lyrEps":-1.283913,"volumeRatio":0.8726528774616679,"shares":333934387,"dividePrice":0,"high":2.71,"amplitude":0.101167,"preClose":2.57,"low":2.45,"week52Low":1.6385,"pbRate":"1.17","psRate":"4.21","week52High":12.505,"institutionHeld":0,"latestPrice":2.68,"eps":-1.234591,"divideRate":0,"volume":16672516,"delay":0,"ttmEps":-1.234591,"open":2.5,"prevYearClose":7.4,"prevWeekClose":3.13,"prevMonthClose":2.57,"prevQuarterClose":1.72,"fiveDayClose":3.13,"twentyDayClose":1.75,"sixtyDayClose":3.1,"earningDate":1754496000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IOVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554735490","title":"Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2554735490","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554735490?lang=en_us&edition=fundamental","pubTime":"2025-07-25 04:05","pubTimestamp":1753387500,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., July  24, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/24/3121434/0/en/Iovance-Biotherapeutics-to-Host-Second-Quarter-and-First-Half-2025-Financial-Results-and-Corporate-Updates-Webcast-on-Thursday-August-7-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","IOVA","BK4218","HST","BK4588","TIL","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2553243036","title":"Iovance Biotherapeutics Shares up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553243036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553243036?lang=en_us&edition=fundamental","pubTime":"2025-07-23 21:33","pubTimestamp":1753277585,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nL4N3TK1AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2553243641","title":"Iovance Biotherapeutics Shares up 19.8% Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2553243641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553243641?lang=en_us&edition=fundamental","pubTime":"2025-07-23 21:09","pubTimestamp":1753276188,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nL4N3TK17I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2552907104","title":"Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552907104","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552907104?lang=en_us&edition=fundamental","pubTime":"2025-07-19 05:15","pubTimestamp":1752873300,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., July  18, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (\"Iovance\" or the “Company”), a biotechnology company focused on innovating, developing, and delive","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/18/3118211/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","IE00BGHQF748.EUR","IOVA","IE00BKPKM429.USD","BK4112","NDAQ","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","BK4588","LU2210149790.SGD","IE00B3QW5Z07.USD",".IXIC"],"gpt_icon":0},{"id":"2551316450","title":"Iovance Biotherapeutics appoints Roche as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2551316450","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551316450?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:40","pubTimestamp":1752579641,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics (IOVA) announced the appointment of Corleen Roche as Chief Financial Officer, effective August 6th, 2025. Published first o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iovance-biotherapeutics-appoints-roche-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iovance-biotherapeutics-appoints-roche-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2551816488","title":"Goldman Sachs Downgrades Iovance Biotherapeutics to Sell From Buy, Adjusts Price Target to $1 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2551816488","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551816488?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:37","pubTimestamp":1752579460,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc (IOVA) has an average rating of overweight and mean price target of $10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IOVA"],"gpt_icon":0},{"id":"2551164854","title":"Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164854","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164854?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:30","pubTimestamp":1752579000,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., July  15, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115480/0/en/Iovance-Biotherapeutics-Appoints-Corleen-Roche-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOVA","BK4505","CFO","TIL"],"gpt_icon":0},{"id":"2551157621","title":"Barclays Reaffirms Their Buy Rating on Iovance Biotherapeutics (IOVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2551157621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551157621?lang=en_us&edition=fundamental","pubTime":"2025-07-15 16:35","pubTimestamp":1752568518,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson maintained a Buy rating on Iovance Biotherapeutics today and set a price target of $4.00. The company’s shares closed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-buy-rating-on-iovance-biotherapeutics-iova-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-reaffirms-their-buy-rating-on-iovance-biotherapeutics-iova-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IOVA"],"gpt_icon":0},{"id":"2551860601","title":"Iovance Says Amtagvi Shows 49% Response Rate in Real-World Skin Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2551860601","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551860601?lang=en_us&edition=fundamental","pubTime":"2025-07-14 20:25","pubTimestamp":1752495948,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics  said Monday its drug Amtagvi led to a 48.8% objective response rate in a retrospective real-world study of 41 patients with skin cancer.Patients treated earlier, after two or fewer prior therapies, saw a response rate of 60.9%, compared to 33.3% among those with three or more previous treatments, the company said.All participants were treated at authorized centers under current US prescribing guidelines and received at least one follow-up physician assessment, Iovance said.Shares of the company were up more than 4% in recent Monday premarket activity.Price: 1.95, Change: +0.08, Percent Change: +4.28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2551186215","title":"Iovance Biotherapeutics Unveils Corporate Presentation Highlighting Global Leadership and Pipeline in TIL Therapy for Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551186215","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551186215?lang=en_us&edition=fundamental","pubTime":"2025-07-14 20:02","pubTimestamp":1752494530,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc. has released a corporate presentation detailing its achievements and ongoing initiatives in the field of Tumor Infiltrating Lymphocytes  therapy for cancer treatment. The company has treated over 1,000 commercial and clinical patients with its TIL products and reported more than $210 million in total product revenue. Their portfolio includes two approved products and numerous clinical trials across various cancer types, including advanced melanoma and non-small cell lung cancer. Iovance is actively involved in regulatory filings beyond the U.S. and continues to expand its treatment centers globally. The presentation highlights the company's focus on developing innovative therapies to address unmet medical needs. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL4NSQT6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2551185685","title":"Iovance Biotherapeutics announces real-world study data on Amtagvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2551185685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551185685?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:40","pubTimestamp":1752493241,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics (IOVA) announced that a real-world, retrospective study demonstrates the benefit of commercial Amtagvi in real-world clinic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/iovance-biotherapeutics-announces-real-world-study-data-on-amtagvi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/iovance-biotherapeutics-announces-real-world-study-data-on-amtagvi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2551218324","title":"Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2551218324","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551218324?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:30","pubTimestamp":1752492600,"startTime":"0","endTime":"0","summary":"61% Response Rate Observed in Third-Line or Earlier Patients SAN CARLOS, Calif., July  14, 2025  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/14/3114660/0/en/Real-World-Data-Demonstrate-a-49-Response-Rate-for-Commercial-Amtagvi-in-Patients-with-Advanced-Melanoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","ORR","BK4505","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4139","TIL","IOVA","IE00B66KJ199.SGD","AEIS","BK4157"],"gpt_icon":0},{"id":"2550675962","title":"Iovance Biotherapeutics Files Initial Ownership Statement for Matthew W. Rosinack, SVP Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2550675962","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550675962?lang=en_us&edition=fundamental","pubTime":"2025-07-11 04:05","pubTimestamp":1752177957,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Matthew W. Rosinack as the beneficial owner, serving as the Senior Vice President of Finance . The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL6W071J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2550675506","title":"Press Release: Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2550675506","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550675506?lang=en_us&edition=fundamental","pubTime":"2025-07-11 04:01","pubTimestamp":1752177660,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., July 10, 2025  -- Iovance Biotherapeutics, Inc. , a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte  therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance's pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte  therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. Iov","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4600","BK4596","BK4588","BK4022","BK4555","03160","BK4139","BK4585","BK4023","R","BK4099","BK4595","TM","BK4516","BK4505","TIL","BK4604","STRK","IOVA","BK4232"],"gpt_icon":1},{"id":"2549273213","title":"Is This Beaten-Down Stock a Millionaire Maker?","url":"https://stock-news.laohu8.com/highlight/detail?id=2549273213","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549273213?lang=en_us&edition=fundamental","pubTime":"2025-07-06 18:47","pubTimestamp":1751798820,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics has proven to be an innovative biotech.Let's find out.Image source: Getty Images.An innovative approach to treating cancerIovance Biotherapeutics' claim to fame is that it developed Amtagvi, a medicine for advanced melanoma . There are at least two important things to note about this product. First, it is manufactured from patients' tumor-infiltrating lymphocytes , a type of white blood cell that destroys cancer cells. Second, Amtagvi became the first medicine of its kind approved by the U.S. Food and Drug Administration for the treatment of metastatic melanoma.It's not surprising, then, that Amtagvi's sales have been growing at a good clip. Iovance Biotherapeutics expects to generate $275 million this year  after racking up $164.1 million in revenue last year. The company's long-term strategy seems simple enough. It is currently seeking approval for Amtagvi in other regions, after which it will look to earn label expansions for the medicine.Then, Iovance Biothe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/06/is-this-beaten-down-stock-a-millionaire-maker/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2548387384","title":"Iovance Biotherapeutics Appoints Matthew W. Rosinack as Interim Principal Financial Officer Following Departure of Jean-Marc Bellemin","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387384","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387384?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:06","pubTimestamp":1751573199,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Appoints Matthew W. Rosinack as Interim Principal Financial Officer Following Departure of Jean-Marc Bellemin. Iovance Biotherapeutics Inc. has announced the resignation of Jean-Marc Bellemin as Chief Financial Officer, effective June 30, 2025. Matthew W. Rosinack has been appointed as the interim Principal Financial Officer and Principal Accounting Officer. Rosinack has been with Iovance as Senior Vice President, Finance since September 2021 and has previous experience with Berkeley Lights, Inc., ZELTIQ Aesthetics, Inc., and FormFactor, Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data G","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL69HDNl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","LU0661504455.SGD","SG9999015978.USD","LU1093756325.SGD","LU2112291526.USD","LU1496350502.SGD","BK4534","LU0310799852.SGD","SG9999015986.USD","IE0002141913.USD","BK4585","LU0029864427.USD","LU0256863811.USD","BK4533","LU2237443549.SGD","LU2087621335.USD","BRKR","IOVA","IE00B4R5TH58.HKD","LU0114720955.EUR","LU0689472784.USD","LU1003077747.HKD","LU0203347892.USD","LU1934455194.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0545039389.USD","FORM","BK4139","LU0965509283.SGD","LU1291159041.SGD","LU2237443622.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU1037948897.HKD","SG9999015952.SGD","IE00BVYPNV92.GBP","LU1585245621.USD","LU1989772840.SGD","LU2237443382.USD","LU1162221912.USD","LU0795875169.SGD","LU1551013342.USD","ABBV","LU1244550494.USD","LU0882574055.USD","BK4602","LU0234570918.USD","LU2089984988.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2546227780","title":"BRIEF-Iovance Biotherapeutics Says Confirming Resignation Of Chief Financial Officer Jean-Marc Bellemin, Effective July 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2546227780","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546227780?lang=en_us&edition=fundamental","pubTime":"2025-06-26 08:39","pubTimestamp":1750898382,"startTime":"0","endTime":"0","summary":"BRIEF-Iovance Biotherapeutics Says Confirming Resignation Of Chief Financial Officer Jean-Marc Bellemin, Effective July 10, 2025June 25 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:IOVANCE BIOTHERAP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nFWN3SS0QR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOVA"],"gpt_icon":1},{"id":"2544179192","title":"Gene Therapy Stocks Fall as FDA Pushes Out Another Top Regulator -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2544179192","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544179192?lang=en_us&edition=fundamental","pubTime":"2025-06-20 23:56","pubTimestamp":1750434960,"startTime":"0","endTime":"0","summary":"The latest departure of a top Food and Drug Administration official is setting off a new round of worries for biotech investors, two months after the fiery resignation of another senior FDA regulator unsettled the sector.The director of the FDA office responsible for regulating gene therapies and cell therapies, Dr. Nicole Verdun, was placed on administrative leave on Wednesday, according to a report by STAT. The healthcare news outlet reported that Verdun had told her staff that she and a deputy had been \"relieved of our duties, for now\" and were \"escorted out.\". \"Center directors deserve to be supported by managers that are aligned with aggressive goals to expeditiously advance therapeutics for rare diseases using the gold standard of science,\" a spokesperson for the Department of Health and Human Services told Barron's in response to a question about the reported departure.Sarepta Therapeutics, which sells a gene therapy to treat Duchenne muscular dystrophy and made headlines last w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","SRPT","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IOVA"],"gpt_icon":0},{"id":"2544278913","title":"Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart","url":"https://stock-news.laohu8.com/highlight/detail?id=2544278913","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544278913?lang=en_us&edition=fundamental","pubTime":"2025-06-18 05:34","pubTimestamp":1750196057,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics (IOVA) said Tuesday that Chief Financial Officer Jean-Marc Bellemin will step down effective July 10.Bellemin is leaving the company to pursue other opportunities, Iovance said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2543658166","title":"Iovance Biotherapeutics Inc. Announces CFO Jean-Marc Bellemin's Resignation Effective July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2543658166","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543658166?lang=en_us&edition=fundamental","pubTime":"2025-06-14 05:16","pubTimestamp":1749849366,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc. announced that Chief Financial Officer Jean-Marc Bellemin will resign from his position effective July 10, 2025. Bellemin, who has served as the principal financial and accounting officer since November 2020, is leaving to pursue other opportunities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL6V8lH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOVA"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":111,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IOVA\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"IOVA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"defaultRemindTime":1754596800000,"name":null,"time":"Post Market","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"IOVA","fiscalQuarterEnding":"2025/03","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-02-27","symbol":"IOVA","fiscalQuarterEnding":"2024/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-07","symbol":"IOVA","fiscalQuarterEnding":"2024/09","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2024-08-08","symbol":"IOVA","fiscalQuarterEnding":"2024/06","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IOVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IOVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0833,"buy":0.5,"hold":0.3333,"sell":0.0833,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1752638400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IOVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IOVA","date":"2025-08-01","current":-2.286344,"percent":0.950447,"low":-30.281556,"twenty":-13.636487,"median":-5.798311,"eighty":-3.358828,"high":-1.476783,"avg":-8.490848,"sd":6.691153,"marketCap":858211374},"quantilePoints":[{"date":"2020-08-07","current":-17.418104,"twenty":-19.443738,"median":-15.73282,"eighty":-12.15061,"marketCap":4279070654},{"date":"2020-08-14","current":-16.565678,"twenty":-19.443738,"median":-15.785324,"eighty":-12.15061,"marketCap":4069656861},{"date":"2020-08-21","current":-17.418104,"twenty":-19.443738,"median":-15.886942,"eighty":-12.15061,"marketCap":4279070654},{"date":"2020-08-28","current":-18.884515,"twenty":-19.443738,"median":-15.941167,"eighty":-12.178846,"marketCap":4639320956},{"date":"2020-09-04","current":-18.27053,"twenty":-19.498658,"median":-15.983538,"eighty":-12.178846,"marketCap":4488484447},{"date":"2020-09-11","current":-18.896437,"twenty":-19.498658,"median":-16.020137,"eighty":-12.178846,"marketCap":4642249820},{"date":"2020-09-18","current":-21.549091,"twenty":-19.595431,"median":-16.066122,"eighty":-12.178846,"marketCap":5293922113},{"date":"2020-09-25","current":-18.962008,"twenty":-19.617516,"median":-16.096093,"eighty":-12.178846,"marketCap":4658358573},{"date":"2020-10-02","current":-18.777216,"twenty":-19.627404,"median":-16.161331,"eighty":-12.26304,"marketCap":4612961178},{"date":"2020-10-09","current":-18.592425,"twenty":-19.627404,"median":-16.23683,"eighty":-12.273198,"marketCap":4567563782},{"date":"2020-10-16","current":-22.437283,"twenty":-19.657246,"median":-16.307973,"eighty":-12.360329,"marketCap":5512122499},{"date":"2020-10-23","current":-22.443244,"twenty":-19.689586,"median":-16.386513,"eighty":-12.405951,"marketCap":5513586931},{"date":"2020-10-30","current":-21.268923,"twenty":-19.731558,"median":-16.408866,"eighty":-12.449823,"marketCap":5225093804},{"date":"2020-11-06","current":-23.285532,"twenty":-19.774119,"median":-16.48374,"eighty":-12.453146,"marketCap":5932035786},{"date":"2020-11-13","current":-21.719344,"twenty":-19.856229,"median":-16.48374,"eighty":-12.453146,"marketCap":5533046238},{"date":"2020-11-20","current":-20.988072,"twenty":-19.908818,"median":-16.510019,"eighty":-12.453146,"marketCap":5346753324},{"date":"2020-11-27","current":-22.675179,"twenty":-19.960796,"median":-16.510111,"eighty":-12.453146,"marketCap":5776547212},{"date":"2020-12-04","current":-24.82293,"twenty":-20.023953,"median":-16.510111,"eighty":-12.453146,"marketCap":6323690968},{"date":"2020-12-11","current":-28.761432,"twenty":-20.028222,"median":-16.510111,"eighty":-12.453146,"marketCap":7327032333},{"date":"2020-12-18","current":-27.241308,"twenty":-20.045394,"median":-16.510111,"eighty":-12.453146,"marketCap":6939777771},{"date":"2020-12-24","current":-28.53111,"twenty":-20.129732,"median":-16.510111,"eighty":-12.453146,"marketCap":7268357399},{"date":"2020-12-31","current":-26.717326,"twenty":-20.175362,"median":-16.510111,"eighty":-12.453146,"marketCap":6806292297},{"date":"2021-01-08","current":-29.089641,"twenty":-20.265077,"median":-16.510111,"eighty":-12.453146,"marketCap":7410644113},{"date":"2021-01-15","current":-29.400575,"twenty":-20.447732,"median":-16.58301,"eighty":-12.453146,"marketCap":7489855274},{"date":"2021-01-22","current":-27.379501,"twenty":-20.469534,"median":-16.613796,"eighty":-12.453146,"marketCap":6974982731},{"date":"2021-01-29","current":-25.243267,"twenty":-20.506773,"median":-16.637268,"eighty":-12.453146,"marketCap":6430772722},{"date":"2021-02-05","current":-28.588691,"twenty":-20.58235,"median":-16.670831,"eighty":-12.453146,"marketCap":7283026133},{"date":"2021-02-12","current":-27.391017,"twenty":-20.643274,"median":-16.732586,"eighty":-12.462125,"marketCap":6977916478},{"date":"2021-02-19","current":-27.172212,"twenty":-20.664719,"median":-16.824864,"eighty":-12.462125,"marketCap":6922175291},{"date":"2021-02-26","current":-21.119905,"twenty":-20.709493,"median":-16.857042,"eighty":-12.462125,"marketCap":5482326136},{"date":"2021-03-05","current":-18.322792,"twenty":-20.759446,"median":-16.95593,"eighty":-12.45999,"marketCap":4756248627},{"date":"2021-03-12","current":-19.642078,"twenty":-20.759446,"median":-17.011882,"eighty":-12.45999,"marketCap":5098710286},{"date":"2021-03-19","current":-17.756575,"twenty":-20.759446,"median":-17.041017,"eighty":-12.484753,"marketCap":4609269374},{"date":"2021-03-26","current":-16.23345,"twenty":-20.739276,"median":-17.064442,"eighty":-12.512749,"marketCap":4213895183},{"date":"2021-04-01","current":-18.243521,"twenty":-20.739276,"median":-17.084335,"eighty":-12.520147,"marketCap":4735671531},{"date":"2021-04-09","current":-17.0941,"twenty":-20.759446,"median":-17.137834,"eighty":-12.518357,"marketCap":4437303648},{"date":"2021-04-16","current":-17.065789,"twenty":-20.759446,"median":-17.143897,"eighty":-12.518357,"marketCap":4429954685},{"date":"2021-04-23","current":-17.711277,"twenty":-20.759446,"median":-17.168139,"eighty":-12.518357,"marketCap":4597511033},{"date":"2021-04-30","current":-18.42951,"twenty":-20.759446,"median":-17.22139,"eighty":-12.518357,"marketCap":4783950674},{"date":"2021-05-07","current":-16.423085,"twenty":-20.759446,"median":-17.229992,"eighty":-12.518357,"marketCap":4359261522},{"date":"2021-05-14","current":-14.868305,"twenty":-20.759446,"median":-17.22139,"eighty":-12.518357,"marketCap":3946568461},{"date":"2021-05-21","current":-10.393993,"twenty":-20.759446,"median":-17.198445,"eighty":-12.484753,"marketCap":2758929540},{"date":"2021-05-28","current":-10.693432,"twenty":-20.759446,"median":-17.159363,"eighty":-12.439439,"marketCap":2838411166},{"date":"2021-06-04","current":-10.319133,"twenty":-20.719106,"median":-17.137834,"eighty":-12.365356,"marketCap":2739059133},{"date":"2021-06-11","current":-13.503553,"twenty":-20.667869,"median":-17.084799,"eighty":-12.358643,"marketCap":3584315662},{"date":"2021-06-18","current":-14.269426,"twenty":-20.643667,"median":-17.071452,"eighty":-12.358643,"marketCap":3787605207},{"date":"2021-06-25","current":-15.565077,"twenty":-20.584911,"median":-17.030346,"eighty":-12.358643,"marketCap":4131516092},{"date":"2021-07-02","current":-15.236845,"twenty":-20.509019,"median":-17.006793,"eighty":-12.358643,"marketCap":4044392001},{"date":"2021-07-09","current":-15.334739,"twenty":-20.492867,"median":-16.95593,"eighty":-12.358643,"marketCap":4070376379},{"date":"2021-07-16","current":-12.950743,"twenty":-20.448368,"median":-16.857507,"eighty":-12.358643,"marketCap":3437580352},{"date":"2021-07-23","current":-13.273215,"twenty":-20.268643,"median":-16.830104,"eighty":-12.358643,"marketCap":3523175950},{"date":"2021-07-30","current":-12.824057,"twenty":-20.177558,"median":-16.774313,"eighty":-12.358643,"marketCap":3403953510},{"date":"2021-08-06","current":-12.860694,"twenty":-20.129517,"median":-16.678937,"eighty":-12.358643,"marketCap":3649453280},{"date":"2021-08-13","current":-11.893683,"twenty":-20.032491,"median":-16.641371,"eighty":-12.298594,"marketCap":3375046640},{"date":"2021-08-20","current":-11.565883,"twenty":-19.96335,"median":-16.613796,"eighty":-12.26791,"marketCap":3282027440},{"date":"2021-08-27","current":-12.844304,"twenty":-19.884377,"median":-16.600342,"eighty":-12.261969,"marketCap":3644802320},{"date":"2021-09-03","current":-13.712974,"twenty":-19.789074,"median":-16.510078,"eighty":-12.261969,"marketCap":3891303200},{"date":"2021-09-10","current":-12.440017,"twenty":-19.742841,"median":-16.47111,"eighty":-12.261969,"marketCap":3530078640},{"date":"2021-09-17","current":-13.915117,"twenty":-19.693215,"median":-16.411608,"eighty":-12.209639,"marketCap":3948665040},{"date":"2021-09-24","current":-13.636487,"twenty":-19.663758,"median":-16.385257,"eighty":-12.209639,"marketCap":3869598720},{"date":"2021-10-01","current":-14.395891,"twenty":-19.617516,"median":-16.302287,"eighty":-12.209639,"marketCap":4085093200},{"date":"2021-10-08","current":-14.434134,"twenty":-19.550148,"median":-16.220949,"eighty":-12.209639,"marketCap":4095945440},{"date":"2021-10-15","current":-14.537938,"twenty":-19.475328,"median":-16.099866,"eighty":-12.209639,"marketCap":4125401520},{"date":"2021-10-22","current":-13.991604,"twenty":-19.420704,"median":-16.073486,"eighty":-12.209639,"marketCap":3970369520},{"date":"2021-10-29","current":-13.28137,"twenty":-19.391439,"median":-16.03075,"eighty":-12.209639,"marketCap":3768827920},{"date":"2021-11-05","current":-12.599546,"twenty":-19.370592,"median":-15.984906,"eighty":-12.209639,"marketCap":3922477950},{"date":"2021-11-12","current":-10.618897,"twenty":-19.352801,"median":-15.960289,"eighty":-12.178873,"marketCap":3305864416},{"date":"2021-11-19","current":-9.489978,"twenty":-19.307194,"median":-15.886942,"eighty":-12.12577,"marketCap":2954410391},{"date":"2021-11-26","current":-9.323664,"twenty":-19.307194,"median":-15.783106,"eighty":-12.043944,"marketCap":2902633683},{"date":"2021-12-03","current":-8.340899,"twenty":-19.307194,"median":-15.73282,"eighty":-11.951653,"marketCap":2596680402},{"date":"2021-12-10","current":-9.308544,"twenty":-19.307194,"median":-15.612663,"eighty":-11.905311,"marketCap":2897926709},{"date":"2021-12-17","current":-9.817566,"twenty":-19.307194,"median":-15.56152,"eighty":-11.869726,"marketCap":3056394818},{"date":"2021-12-23","current":-10.160274,"twenty":-19.307194,"median":-15.507492,"eighty":-11.832958,"marketCap":3163086218},{"date":"2021-12-31","current":-9.621013,"twenty":-19.307194,"median":-15.418706,"eighty":-11.750257,"marketCap":2995204162},{"date":"2022-01-07","current":-8.204824,"twenty":-19.297074,"median":-15.330846,"eighty":-11.620268,"marketCap":2554317641},{"date":"2022-01-14","current":-7.806678,"twenty":-19.297074,"median":-15.268517,"eighty":-11.574625,"marketCap":2430367337},{"date":"2022-01-21","current":-7.035586,"twenty":-19.297074,"median":-15.250034,"eighty":-11.492698,"marketCap":2190311687},{"date":"2022-01-28","current":-7.579887,"twenty":-19.280969,"median":-15.183287,"eighty":-11.427234,"marketCap":2359762734},{"date":"2022-02-04","current":-7.998192,"twenty":-19.280969,"median":-15.154913,"eighty":-11.311986,"marketCap":2489989002},{"date":"2022-02-11","current":-8.492094,"twenty":-19.280969,"median":-15.082045,"eighty":-11.223458,"marketCap":2643750138},{"date":"2022-02-18","current":-8.063709,"twenty":-19.280969,"median":-15.013057,"eighty":-11.057119,"marketCap":2510385888},{"date":"2022-02-25","current":-7.140842,"twenty":-19.280969,"median":-14.987739,"eighty":-11.021101,"marketCap":2443967391},{"date":"2022-03-04","current":-5.956059,"twenty":-19.208679,"median":-14.958479,"eighty":-10.979583,"marketCap":2038473123},{"date":"2022-03-11","current":-6.052495,"twenty":-19.208679,"median":-14.897637,"eighty":-10.887107,"marketCap":2071478470},{"date":"2022-03-18","current":-7.384227,"twenty":-19.16853,"median":-14.846491,"eighty":-10.810905,"marketCap":2527266601},{"date":"2022-03-25","current":-7.806708,"twenty":-19.12079,"median":-14.815366,"eighty":-10.755216,"marketCap":2671861457},{"date":"2022-04-01","current":-7.857222,"twenty":-19.088997,"median":-14.732018,"eighty":-10.641664,"marketCap":2689149972},{"date":"2022-04-08","current":-8.417468,"twenty":-19.088997,"median":-14.621987,"eighty":-10.555613,"marketCap":2880895323},{"date":"2022-04-14","current":-8.091423,"twenty":-19.088997,"median":-14.58308,"eighty":-10.506977,"marketCap":2769305816},{"date":"2022-04-22","current":-7.471479,"twenty":-19.088997,"median":-14.541774,"eighty":-10.446202,"marketCap":2557128582},{"date":"2022-04-29","current":-6.957155,"twenty":-19.088997,"median":-14.496823,"eighty":-10.412129,"marketCap":2381100063},{"date":"2022-05-06","current":-6.340933,"twenty":-19.088997,"median":-14.474931,"eighty":-10.366276,"marketCap":2272653921},{"date":"2022-05-13","current":-6.169912,"twenty":-19.088997,"median":-14.474931,"eighty":-10.333112,"marketCap":2211358276},{"date":"2022-05-20","current":-6.766293,"twenty":-19.088997,"median":-14.474931,"eighty":-10.286006,"marketCap":2425107193},{"date":"2022-05-27","current":-3.078378,"twenty":-19.088997,"median":-14.474931,"eighty":-10.223956,"marketCap":1103321613},{"date":"2022-06-03","current":-3.442346,"twenty":-19.088997,"median":-14.474931,"eighty":-10.198543,"marketCap":1233771319},{"date":"2022-06-10","current":-3.639678,"twenty":-19.088997,"median":-14.474931,"eighty":-10.177376,"marketCap":1304497064},{"date":"2022-06-17","current":-3.841395,"twenty":-19.088997,"median":-14.474931,"eighty":-10.128537,"marketCap":1376794491},{"date":"2022-06-24","current":-4.538635,"twenty":-19.09081,"median":-14.473609,"eighty":-10.099736,"marketCap":1626692122},{"date":"2022-07-01","current":-5.029772,"twenty":-19.09081,"median":-14.425802,"eighty":-10.032779,"marketCap":1802720641},{"date":"2022-07-08","current":-5.490213,"twenty":-19.09081,"median":-14.405445,"eighty":-10.009015,"marketCap":1967747378},{"date":"2022-07-15","current":-5.612998,"twenty":-19.09081,"median":-14.405445,"eighty":-9.964399,"marketCap":2011754508},{"date":"2022-07-22","current":-5.165712,"twenty":-19.09081,"median":-14.405445,"eighty":-9.931566,"marketCap":1851442821},{"date":"2022-07-29","current":-5.108705,"twenty":-19.09081,"median":-14.405445,"eighty":-9.903968,"marketCap":1831010939},{"date":"2022-08-05","current":-5.106191,"twenty":-19.09081,"median":-14.405445,"eighty":-9.88112,"marketCap":1922011076},{"date":"2022-08-12","current":-5.30742,"twenty":-19.09081,"median":-14.405445,"eighty":-9.858167,"marketCap":1997755355},{"date":"2022-08-19","current":-5.03073,"twenty":-19.09081,"median":-14.405445,"eighty":-9.858167,"marketCap":1893606972},{"date":"2022-08-26","current":-4.611502,"twenty":-19.09081,"median":-14.405445,"eighty":-9.858167,"marketCap":1735806391},{"date":"2022-09-02","current":-4.603118,"twenty":-19.09081,"median":-14.405445,"eighty":-9.787327,"marketCap":1732650379},{"date":"2022-09-09","current":-4.695348,"twenty":-19.09081,"median":-14.405445,"eighty":-9.760051,"marketCap":1767366507},{"date":"2022-09-16","current":-4.544426,"twenty":-19.09081,"median":-14.405445,"eighty":-9.656759,"marketCap":1710558298},{"date":"2022-09-23","current":-4.104237,"twenty":-19.09081,"median":-14.386876,"eighty":-9.612949,"marketCap":1544867687},{"date":"2022-09-30","current":-4.016199,"twenty":-19.09081,"median":-14.330519,"eighty":-9.517991,"marketCap":1511729565},{"date":"2022-10-07","current":-4.095853,"twenty":-19.09081,"median":-14.298219,"eighty":-9.489782,"marketCap":1541711676},{"date":"2022-10-14","current":-3.710163,"twenty":-19.09081,"median":-14.246393,"eighty":-9.454391,"marketCap":1396535141},{"date":"2022-10-21","current":-3.86947,"twenty":-19.09081,"median":-14.204674,"eighty":-9.432524,"marketCap":1456499362},{"date":"2022-10-28","current":-4.087468,"twenty":-19.09081,"median":-14.1867,"eighty":-9.371905,"marketCap":1538555664},{"date":"2022-11-04","current":-3.60289,"twenty":-19.09081,"median":-14.11435,"eighty":-9.340876,"marketCap":1404781170},{"date":"2022-11-11","current":-3.594793,"twenty":-19.09081,"median":-14.11435,"eighty":-9.307859,"marketCap":1401624359},{"date":"2022-11-18","current":-2.679902,"twenty":-19.09081,"median":-14.11435,"eighty":-9.265612,"marketCap":1044904646},{"date":"2022-11-25","current":-2.501782,"twenty":-19.09081,"median":-14.11435,"eighty":-9.150839,"marketCap":975454790},{"date":"2022-12-02","current":-2.768963,"twenty":-19.09081,"median":-14.087628,"eighty":-8.989019,"marketCap":1079629574},{"date":"2022-12-09","current":-2.801348,"twenty":-19.09081,"median":-14.087628,"eighty":-8.86249,"marketCap":1092256820},{"date":"2022-12-16","current":-2.619179,"twenty":-19.09081,"median":-14.010282,"eighty":-8.54854,"marketCap":1021228559},{"date":"2022-12-23","current":-2.477493,"twenty":-19.09081,"median":-13.986141,"eighty":-8.486046,"marketCap":965984355},{"date":"2022-12-30","current":-2.586794,"twenty":-19.09081,"median":-13.986141,"eighty":-8.407,"marketCap":1008601312},{"date":"2023-01-06","current":-2.574649,"twenty":-19.09081,"median":-13.986141,"eighty":-8.407,"marketCap":1003866095},{"date":"2023-01-13","current":-2.570601,"twenty":-19.09081,"median":-13.986141,"eighty":-8.407,"marketCap":1002287689},{"date":"2023-01-20","current":-2.538216,"twenty":-19.09081,"median":-13.986141,"eighty":-8.349971,"marketCap":989660442},{"date":"2023-01-27","current":-3.303324,"twenty":-19.09081,"median":-13.953361,"eighty":-8.210872,"marketCap":1287979140},{"date":"2023-02-03","current":-3.230456,"twenty":-19.09081,"median":-13.852322,"eighty":-8.057441,"marketCap":1259567836},{"date":"2023-02-10","current":-2.979468,"twenty":-19.09081,"median":-13.773659,"eighty":-7.949436,"marketCap":1161706676},{"date":"2023-02-17","current":-2.97542,"twenty":-19.09081,"median":-13.676307,"eighty":-7.809463,"marketCap":1160128270},{"date":"2023-02-24","current":-2.833734,"twenty":-19.06279,"median":-13.636487,"eighty":-7.727723,"marketCap":1104884067},{"date":"2023-03-03","current":-4.163134,"twenty":-19.039225,"median":-13.581854,"eighty":-7.604652,"marketCap":1648155782},{"date":"2023-03-10","current":-3.517424,"twenty":-18.94915,"median":-13.472587,"eighty":-7.531351,"marketCap":1392523457},{"date":"2023-03-17","current":-3.659027,"twenty":-18.94915,"median":-13.434344,"eighty":-7.407929,"marketCap":1448583177},{"date":"2023-03-24","current":-3.132263,"twenty":-18.94915,"median":-13.360255,"eighty":-7.327736,"marketCap":1240041017},{"date":"2023-03-31","current":-3.460783,"twenty":-18.944864,"median":-13.298091,"eighty":-7.157669,"marketCap":1370099569},{"date":"2023-04-06","current":-3.324843,"twenty":-18.944864,"median":-13.23753,"eighty":-7.08377,"marketCap":1316282237},{"date":"2023-04-14","current":-3.296523,"twenty":-18.94915,"median":-13.129254,"eighty":-6.94246,"marketCap":1305070293},{"date":"2023-04-21","current":-3.151997,"twenty":-18.94915,"median":-13.094578,"eighty":-6.73673,"marketCap":1247853376},{"date":"2023-04-28","current":-3.037599,"twenty":-18.94915,"median":-12.997277,"eighty":-6.51634,"marketCap":1202564127},{"date":"2023-05-05","current":-3.882006,"twenty":-18.94915,"median":-12.950743,"eighty":-6.375137,"marketCap":1536859006},{"date":"2023-05-12","current":-4.087618,"twenty":-18.94915,"median":-12.860694,"eighty":-6.156258,"marketCap":1682692342},{"date":"2023-05-19","current":-4.056536,"twenty":-18.94915,"median":-12.819866,"eighty":-5.841255,"marketCap":1669897241},{"date":"2023-05-26","current":-4.192844,"twenty":-18.94915,"median":-12.682511,"eighty":-5.649833,"marketCap":1726009380},{"date":"2023-06-02","current":-4.759887,"twenty":-18.94915,"median":-12.636725,"eighty":-5.495476,"marketCap":1959435876},{"date":"2023-06-09","current":-4.361866,"twenty":-18.94915,"median":-12.623644,"eighty":-5.436714,"marketCap":1795588432},{"date":"2023-06-16","current":-4.710816,"twenty":-18.94915,"median":-12.623644,"eighty":-5.319746,"marketCap":1939235506},{"date":"2023-06-23","current":-4.427294,"twenty":-18.953436,"median":-12.628405,"eighty":-5.259554,"marketCap":1822522258},{"date":"2023-06-30","current":-3.843895,"twenty":-18.957722,"median":-12.623644,"eighty":-5.190036,"marketCap":1582362305},{"date":"2023-07-07","current":-3.713039,"twenty":-18.957722,"median":-12.623644,"eighty":-5.112213,"marketCap":1528494652},{"date":"2023-07-14","current":-4.616488,"twenty":-18.957722,"median":-12.60938,"eighty":-5.036523,"marketCap":1900404894},{"date":"2023-07-21","current":-4.580421,"twenty":-18.957722,"median":-12.545155,"eighty":-4.944582,"marketCap":1885557981},{"date":"2023-07-28","current":-4.225769,"twenty":-18.957722,"median":-12.503789,"eighty":-4.884343,"marketCap":1739563334},{"date":"2023-08-04","current":-4.34599,"twenty":-18.957722,"median":-12.440017,"eighty":-4.828494,"marketCap":1789053045},{"date":"2023-08-11","current":-4.253499,"twenty":-18.957722,"median":-12.315065,"eighty":-4.793691,"marketCap":1781514135},{"date":"2023-08-18","current":-3.70924,"twenty":-18.957722,"median":-12.16685,"eighty":-4.72519,"marketCap":1553559614},{"date":"2023-08-25","current":-3.596839,"twenty":-18.957722,"median":-11.906077,"eighty":-4.676399,"marketCap":1506482050},{"date":"2023-09-01","current":-3.573176,"twenty":-18.957722,"median":-11.856638,"eighty":-4.612499,"marketCap":1496570984},{"date":"2023-09-08","current":-3.431195,"twenty":-18.957722,"median":-11.834666,"eighty":-4.589703,"marketCap":1437104587},{"date":"2023-09-15","current":-2.747914,"twenty":-18.957722,"median":-11.620542,"eighty":-4.531619,"marketCap":1150922553},{"date":"2023-09-22","current":-2.978632,"twenty":-18.957722,"median":-11.475132,"eighty":-4.492722,"marketCap":1247555447},{"date":"2023-09-29","current":-2.697629,"twenty":-18.957722,"median":-11.473006,"eighty":-4.460122,"marketCap":1129861537},{"date":"2023-10-06","current":-2.472827,"twenty":-18.957722,"median":-11.473006,"eighty":-4.405485,"marketCap":1035706409},{"date":"2023-10-13","current":-2.147455,"twenty":-18.957722,"median":-11.467543,"eighty":-4.357504,"marketCap":899429250},{"date":"2023-10-20","current":-1.952232,"twenty":-18.957722,"median":-11.383938,"eighty":-4.322309,"marketCap":817662954},{"date":"2023-10-27","current":-2.188866,"twenty":-18.988236,"median":-11.413922,"eighty":-4.29829,"marketCap":916773616},{"date":"2023-11-03","current":-2.295351,"twenty":-18.988236,"median":-11.413922,"eighty":-4.237792,"marketCap":961373413},{"date":"2023-11-10","current":-2.334715,"twenty":-18.988236,"median":-11.413922,"eighty":-4.209194,"marketCap":1010877869},{"date":"2023-11-17","current":-2.600695,"twenty":-18.988236,"median":-11.413922,"eighty":-4.174481,"marketCap":1126041171},{"date":"2023-11-24","current":-3.422278,"twenty":-18.988236,"median":-11.413922,"eighty":-4.156344,"marketCap":1481767813},{"date":"2023-12-01","current":-3.587777,"twenty":-18.988236,"median":-11.413922,"eighty":-4.112149,"marketCap":1553424979},{"date":"2023-12-08","current":-3.977881,"twenty":-18.975122,"median":-11.393933,"eighty":-4.087588,"marketCap":1722331155},{"date":"2023-12-15","current":-4.557127,"twenty":-18.975122,"median":-11.393933,"eighty":-4.081186,"marketCap":1973131234},{"date":"2023-12-22","current":-4.663519,"twenty":-18.975122,"median":-11.393933,"eighty":-4.081186,"marketCap":2019196554},{"date":"2023-12-29","current":-5.071355,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":2195780283},{"date":"2024-01-05","current":-4.793554,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":2075498613},{"date":"2024-01-12","current":-5.408264,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":2341653799},{"date":"2024-01-19","current":-4.693073,"twenty":-19.014465,"median":-11.443907,"eighty":-4.078926,"marketCap":2031992477},{"date":"2024-01-26","current":-4.515752,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":1955216942},{"date":"2024-02-02","current":-4.764001,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":2062702690},{"date":"2024-02-09","current":-5.130462,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":2221372128},{"date":"2024-02-16","current":-5.833832,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":2525915081},{"date":"2024-02-23","current":-10.268867,"twenty":-19.001351,"median":-11.433912,"eighty":-4.079679,"marketCap":4446183221},{"date":"2024-03-01","current":-10.007668,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":4443775054},{"date":"2024-03-08","current":-10.454271,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":4642083054},{"date":"2024-03-15","current":-8.938339,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":3968953081},{"date":"2024-03-22","current":-9.661709,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":4290156180},{"date":"2024-03-28","current":-8.869147,"twenty":-18.988236,"median":-11.413922,"eighty":-4.080433,"marketCap":3938229306},{"date":"2024-04-05","current":-8.554638,"twenty":-19.001351,"median":-11.383938,"eighty":-4.079679,"marketCap":3798575784},{"date":"2024-04-12","current":-8.296741,"twenty":-19.001351,"median":-11.117889,"eighty":-4.079679,"marketCap":3684059897},{"date":"2024-04-19","current":-7.372085,"twenty":-19.001351,"median":-11.014135,"eighty":-4.079679,"marketCap":3273478543},{"date":"2024-04-26","current":-7.258862,"twenty":-18.988236,"median":-10.85428,"eighty":-4.080433,"marketCap":3223203276},{"date":"2024-05-03","current":-8.116972,"twenty":-18.988236,"median":-10.693742,"eighty":-4.080433,"marketCap":3604235799},{"date":"2024-05-10","current":-8.476186,"twenty":-18.988236,"median":-10.643517,"eighty":-4.080433,"marketCap":3763740023},{"date":"2024-05-17","current":-6.49105,"twenty":-18.988236,"median":-10.590051,"eighty":-4.080433,"marketCap":2918655290},{"date":"2024-05-24","current":-6.385252,"twenty":-18.988236,"median":-10.393993,"eighty":-4.080433,"marketCap":2871083727},{"date":"2024-05-31","current":-5.601098,"twenty":-18.988236,"median":-10.250812,"eighty":-4.080433,"marketCap":2518494498},{"date":"2024-06-07","current":-5.065882,"twenty":-18.988236,"median":-10.01944,"eighty":-4.080433,"marketCap":2277838357},{"date":"2024-06-14","current":-5.246362,"twenty":-19.001351,"median":-9.908283,"eighty":-4.079679,"marketCap":2358989846},{"date":"2024-06-21","current":-4.960083,"twenty":-18.895245,"median":-9.802446,"eighty":-4.078926,"marketCap":2230266794},{"date":"2024-06-28","current":-4.984977,"twenty":-18.851934,"median":-9.731889,"eighty":-4.075411,"marketCap":2241460103},{"date":"2024-07-05","current":-4.599124,"twenty":-18.803956,"median":-9.600854,"eighty":-4.075411,"marketCap":2067963815},{"date":"2024-07-12","current":-5.252585,"twenty":-18.755671,"median":-9.447843,"eighty":-4.075411,"marketCap":2361788173},{"date":"2024-07-15","current":-5.433065,"twenty":-18.738676,"median":-9.43958,"eighty":-4.075411,"marketCap":2442939663},{"date":"2024-08-02","current":-5.078329,"twenty":-18.607613,"median":-9.322852,"eighty":-4.062314,"marketCap":2283435011},{"date":"2024-08-09","current":-5.047231,"twenty":-18.592425,"median":-9.262283,"eighty":-4.062314,"marketCap":2221871812},{"date":"2024-08-16","current":-7.3566,"twenty":-18.592425,"median":-9.008675,"eighty":-4.062314,"marketCap":3238493014},{"date":"2024-08-23","current":-8.011592,"twenty":-18.592425,"median":-8.872134,"eighty":-4.062314,"marketCap":3526831192},{"date":"2024-08-30","current":-7.846121,"twenty":-18.592425,"median":-8.811363,"eighty":-4.062314,"marketCap":3453987863},{"date":"2024-09-06","current":-7.211812,"twenty":-18.592425,"median":-8.745257,"eighty":-4.062314,"marketCap":3174755101},{"date":"2024-09-13","current":-6.522346,"twenty":-18.592425,"median":-8.553605,"eighty":-4.062314,"marketCap":2871241229},{"date":"2024-09-20","current":-7.135971,"twenty":-18.592425,"median":-8.484534,"eighty":-4.062314,"marketCap":3141368575},{"date":"2024-09-27","current":-6.377559,"twenty":-18.592425,"median":-8.404383,"eighty":-4.062314,"marketCap":2807503316},{"date":"2024-10-04","current":-6.729186,"twenty":-18.592425,"median":-8.306176,"eighty":-4.062314,"marketCap":2962295390},{"date":"2024-10-11","current":-6.529241,"twenty":-18.592425,"median":-8.218082,"eighty":-4.062314,"marketCap":2874276367},{"date":"2024-10-18","current":-7.011867,"twenty":-18.592425,"median":-8.136676,"eighty":-4.062314,"marketCap":3086736078},{"date":"2024-10-25","current":-7.280759,"twenty":-18.592425,"median":-8.056982,"eighty":-4.062314,"marketCap":3205106488},{"date":"2024-10-31","current":-7.611702,"twenty":-18.592425,"median":-8.004892,"eighty":-4.062314,"marketCap":3350793146},{"date":"2024-11-08","current":-9.090677,"twenty":-18.595463,"median":-7.972027,"eighty":-4.061158,"marketCap":3727150348},{"date":"2024-11-15","current":-6.385576,"twenty":-18.595463,"median":-7.868606,"eighty":-4.061158,"marketCap":2618066986},{"date":"2024-11-22","current":-6.125395,"twenty":-18.595463,"median":-7.816758,"eighty":-4.061158,"marketCap":2511393709},{"date":"2024-11-29","current":-6.928238,"twenty":-18.595463,"median":-7.806678,"eighty":-4.061158,"marketCap":2840556962},{"date":"2024-12-06","current":-6.296371,"twenty":-18.553356,"median":-7.749967,"eighty":-4.061158,"marketCap":2581493291},{"date":"2024-12-13","current":-5.917251,"twenty":-18.492341,"median":-7.668943,"eighty":-4.061158,"marketCap":2426055088},{"date":"2024-12-20","current":-5.367155,"twenty":-18.393963,"median":-7.604652,"eighty":-4.061158,"marketCap":2200517303},{"date":"2024-12-27","current":-5.649636,"twenty":-18.310947,"median":-7.577099,"eighty":-4.061158,"marketCap":2316334004},{"date":"2025-01-03","current":-5.790877,"twenty":-18.239152,"median":-7.480704,"eighty":-4.061158,"marketCap":2374242354},{"date":"2025-01-10","current":-5.329986,"twenty":-18.105341,"median":-7.456637,"eighty":-4.060003,"marketCap":2185278264},{"date":"2025-01-17","current":-4.28183,"twenty":-17.998615,"median":-7.412914,"eighty":-4.060003,"marketCap":1755537350},{"date":"2025-01-24","current":-4.60148,"twenty":-17.99268,"median":-7.381931,"eighty":-4.060003,"marketCap":1886593090},{"date":"2025-01-31","current":-4.616348,"twenty":-17.99268,"median":-7.344768,"eighty":-4.060003,"marketCap":1892688705},{"date":"2025-02-07","current":-4.371035,"twenty":-17.99268,"median":-7.274088,"eighty":-4.060003,"marketCap":1792111045},{"date":"2025-02-14","current":-3.969613,"twenty":-17.99268,"median":-7.211812,"eighty":-4.02245,"marketCap":1627529418},{"date":"2025-02-21","current":-4.170324,"twenty":-17.904851,"median":-7.171722,"eighty":-4.02245,"marketCap":1709820231},{"date":"2025-02-28","current":-4.307485,"twenty":-17.703143,"median":-7.124777,"eighty":-4.014886,"marketCap":1603146955},{"date":"2025-03-07","current":-3.303637,"twenty":-17.591239,"median":-7.06013,"eighty":-3.984824,"marketCap":1229537602},{"date":"2025-03-14","current":-3.101014,"twenty":-17.545836,"median":-6.975523,"eighty":-3.96235,"marketCap":1154125962},{"date":"2025-03-21","current":-3.118633,"twenty":-17.545836,"median":-6.928238,"eighty":-3.931521,"marketCap":1160683496},{"date":"2025-03-28","current":-3.19792,"twenty":-17.418104,"median":-6.888272,"eighty":-3.915585,"marketCap":1190192399},{"date":"2025-04-04","current":-2.863152,"twenty":-17.344719,"median":-6.824004,"eighty":-3.871156,"marketCap":1065599255},{"date":"2025-04-11","current":-2.695768,"twenty":-17.174894,"median":-6.770829,"eighty":-3.847166,"marketCap":1003302683},{"date":"2025-04-17","current":-2.704577,"twenty":-17.088212,"median":-6.739562,"eighty":-3.780465,"marketCap":1006581450},{"date":"2025-04-25","current":-2.960058,"twenty":-16.996419,"median":-6.715397,"eighty":-3.753378,"marketCap":1101665691},{"date":"2025-05-02","current":-2.933629,"twenty":-16.764775,"median":-6.66024,"eighty":-3.731837,"marketCap":1091829391},{"date":"2025-05-09","current":-2.768963,"twenty":-16.587166,"median":-6.625766,"eighty":-3.709609,"marketCap":1039369119},{"date":"2025-05-16","current":-1.565746,"twenty":-15.551257,"median":-6.52511,"eighty":-3.693704,"marketCap":587724521},{"date":"2025-05-23","current":-1.556849,"twenty":-15.269092,"median":-6.489648,"eighty":-3.645879,"marketCap":584385177},{"date":"2025-05-30","current":-1.62802,"twenty":-15.13527,"median":-6.446505,"eighty":-3.63825,"marketCap":611099928},{"date":"2025-06-06","current":-1.601331,"twenty":-14.826844,"median":-6.428816,"eighty":-3.599259,"marketCap":601081896},{"date":"2025-06-13","current":-2.055041,"twenty":-14.566562,"median":-6.385576,"eighty":-3.586347,"marketCap":771388433},{"date":"2025-06-20","current":-1.814841,"twenty":-14.393706,"median":-6.36484,"eighty":-3.567394,"marketCap":681226149},{"date":"2025-06-27","current":-1.547953,"twenty":-14.306426,"median":-6.298777,"eighty":-3.546291,"marketCap":581045833},{"date":"2025-07-03","current":-1.556849,"twenty":-14.250999,"median":-6.199789,"eighty":-3.517424,"marketCap":584385177},{"date":"2025-07-11","current":-1.716982,"twenty":-14.162007,"median":-6.08451,"eighty":-3.475864,"marketCap":644493366},{"date":"2025-07-18","current":-2.08173,"twenty":-13.919488,"median":-5.975283,"eighty":-3.444498,"marketCap":781406465},{"date":"2025-07-25","current":-2.926877,"twenty":-13.785021,"median":-5.842135,"eighty":-3.422278,"marketCap":1098644133},{"date":"2025-08-01","current":-2.286344,"twenty":-13.636487,"median":-5.798311,"eighty":-3.358828,"marketCap":858211374}],"updateTime":1754140064341}}}